VMA21 anticorps

N° du produit ABIN7254226

Cet anticorps anti-VMA21 est un anticorps Lapin Polyclonal détectant VMA21 dans ELISA, IHC et IF. Adapté pour Humain et Souris.

Aperçu rapide pour VMA21 anticorps (ABIN7254226)

Antigène: VMA21 (Vacuolar H+-ATPase Homolog (VMA21))

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp VMA21 est non-conjugé

Application: ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Détail du produit anti-VMA21 anticorps

Attributs du produit: Polyclonal Antibody

Purification: Antigen affinity purification

Immunogène: Synthetic peptide of human VMA21

Isotype: IgG

Information d'application

Indications d'application: IHC 1:150-1:500, IF 1: 50-1:200, ELISA 1:5000-1:240000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 2.6 mg/mL

Buffer: PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur VMA21

Antigène: VMA21 (Vacuolar H+-ATPase Homolog (VMA21))

Autre désignation: VMA21

Sujet: This gene encodes a chaperone for assembly of lysosomal vacuolar ATPase. Required for the assembly of the V0 complex of the vacuolar ATPase (V-ATPase) in the endoplasmic reticulum. Associates with the V0 complex of the vacuolar ATPase (V-ATPase). MEAX is a childhood-onset disease characterized by progressive vacuolation and atrophy of skeletal muscle. It is inherited in recessive fashion, affecting boys and sparing carrier females. Onset is in childhood, and patients exhibit weakness of the proximal muscles of the lower extremities, progressing slowly to involve other skeletal muscle groups over time.

UniProt: Q3ZAQ7